Microarray gene data should be made public
A team of researchers has issued a plea that that microarray-derived gene expression data should be available in a public repository in the same way that gene sequence data is collated for use by all.
A team of researchers has issued a plea that that microarray-derived gene expression data should be available in a public repository in the same way that gene sequence data is collated for use by all.
A new approach to treating obesity which blocks brain signals that control cravings has shown promising results in human subjects during advanced clinical trials paving the way for further testing and an eventual launch date.
Germany's Bayer has reported a mixed set of results for the second quarter with fine chemicals offshoot Lanxess contributing to an unexpected 44 per cent hike in earnings before interest and tax (EBIT).
Rhodia Pharma Solutions' Chambers Works facility in New Jersey is now up and running. The company supplies preclinical and clinical trial materials and launch volumes of active pharmaceutical ingredients (APIs) and intermediates from the site.
Ashland of the US has signed an agreement to sell the ingestibles line of business of Ashland Distribution - which includes pharmaceutical actives and excipients and food and beverage additives - to Japan's Mitsubishi Corp.